Objectives: To implement the Cardiovascular Practice Transformation (CPT) program and evaluate its impact on blood pressure, and to assess the feasibility of implementing the CPT program by identifying obstacles and facilitators.
Methods: Twenty-three Iowa pharmacies participated in the program, each monitoring approximately 10 hypertensive patients for 6 months. Pharmacists assessed blood pressure, medication adherence and addressed medication-related problems during patient visits. Pharmacists used a JotForm application to report patient demographics and care provided during visits. Also, blood pressure readings were collected or measured and reported. After six months, an online Qualtrics survey was sent to participating pharmacies to assess obstacles and facilitators to CPT program implementation. Descriptive statistics were calculated for the patient sample and paired -tests compared baseline and final blood pressure readings. Frequencies were calculated for obstacles and facilitators.
Results: A total of 232 patients participated, with 138 patients having both baseline and follow-up blood pressure data. Systolic blood pressure decreased from 144.2 to 133.6 mmHg, and diastolic blood pressure decreased from 84.4 to 78.3 mmHg, with < 0.01 for both. Peer coaching and CPT resources were the main facilitators, while obstacles included documentation and staff time constraints.
Conclusion: Overall, the CPT program successfully supported pharmacies in improving blood pressure management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11750546 | PMC |
http://dx.doi.org/10.1016/j.rcsop.2024.100559 | DOI Listing |
J Med Internet Res
January 2025
Centre for Research in Media and Communication, Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Background: Cardiovascular disease (CVD) is a major global health issue, with approximately 70% of cases linked to modifiable risk factors. Digital health solutions offer potential for CVD prevention; yet, their effectiveness in covering the full range of prevention strategies is uncertain.
Objective: This study aimed to synthesize current literature on digital solutions for CVD prevention, identify the key components of effective digital interventions, and highlight critical research gaps to inform the development of sustainable strategies for CVD prevention.
Int J Clin Pharm
January 2025
Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
Background: Deprescribing inappropriate cardiovascular and antidiabetic medication has been shown to be feasible and safe. Healthcare providers often perceive the deprescribing of cardiovascular and antidiabetic medication as a challenge and therefore it is still not widely implemented in daily practice.
Aim: The aim was to assess whether training focused on conducting a deprescribing-oriented clinical medication review (CMR) results in a reduction of the inappropriate use of cardiovascular and antidiabetic medicines.
World J Pediatr
January 2025
Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China.
Background: We performed an umbrella review to synthesize evidence on the effects of physical activity (PA) interventions on indicators of physical and psychological health among children and adolescents, including body mass index (BMI), blood pressure (BP), depressive symptoms, and cognitive function.
Methods: PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception through 31 July 2023. We included meta-analyses of randomized controlled trials exploring the effects of PA interventions on BMI, BP, depressive symptoms, or cognitive function in healthy or general children and adolescents.
Curr Cardiol Rep
January 2025
John Ochsner Heart and Vascular Institute, Ochsner Clinical School University of Queensland School of Medicine, New Orleans, LA, USA.
Purpose Of Review: To provide a narrative overview of trends and disparities in the cardiometabolic profiles of U.S. adults by synthesizing findings from nationally representative studies conducted between 1999 and 2020.
View Article and Find Full Text PDFMinerva Cardiol Angiol
January 2025
Department of Neurology, Traditional Chinese Medical Hospital of Huzhou, Huzhou, Zhejiang, China -
Introduction: The current meta-analysis aimed to determine the efficacy of propolis supplementation on hypertension.
Evidence Acquisition: The systematic review and meta-analysis. were undertaken on five online databases to find clinical trials assessing the effects of propolis on systolic blood pressure (SBP) and diastolic blood pressure (DBP) markers up to October 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!